The diagnosis of neuromuscular disorders, including SMA, in young children is often delayed, preventing patients from receiving the management and services they require.2

With treatment now available for SMA, its relative effectiveness may depend on being able to identify patients early enough to initiate treatment before irreversible neuronal loss occurs.1,3

The Red Flags Checklist offers healthcare professionals a simple reminder to help recognise the early signs of SMA and other neuromuscular disorders (NMDs).

If you suspect SMA or another NMD in any of your patients, refer immediately to your local neuromuscular clinic

A simple genetic test can confirm the diagnosis of SMA so treatment can be initiated earlier to improve outcomes.1

Find your nearest neuromuscular clinic using our Clinic Finder.


Learn more and gain CPD points with an accredited module on paediatric neuromuscular disorders

  • 1-hour online education module
  • RACGP accredited for two category 2 QI&CPD points
  • Developed in collaboration with a panel of Australian paediatric neuromuscular experts
  1. D’Amico D et al. Orphanet J Rare Dis 2011; 6: 71.
  2. Lurio J et al. Am Fam Physician 2015; 91: 38–4.
  3. Finkel RS et al. N Engl J Med 2017; 377: 1723–32.